Background: Thyroid cytology reporting has become standardized with the introduction of the Bethesda System of Reporting Thyroid Cytology (BSRTC), linking up diagnostic categories with clinical management guidelines. The current thyroid cytology reporting format in Sri Lanka (TCRSL) is based on the original 'Thy' classification of the British Thyroid Association. The number of diagnostic categories have been increased in the BSRTC than in TCRSL (6 vs. 5 categories), with a possible adverse impact on inter-observer agreement (IOA). IOA of both reporting formats were thus compared to evaluate the appropriateness of looking beyond TCRSL in Sri Lanka, a country facing a significant thyroid cytology burden.
Introduction
Thyroid enlargement is a frequent clinical presentation of thyroid disease with a reported prevalence of 7 % in the general population (1) . Incidence of thyroid cancer is approximately 213,000 new cases per year worldwide, and accounts for 5.6% of all cancers and for 8.1% of cancers in females in Sri Lanka (2, 3) . It is important to differentiate neoplastic from non neoplastic thyroid enlargement, to provide optimum healthcare to affected patients. Thyroid fine needle aspiration cytology (T-FNAC) is a widely accepted diagnostic tool for preoperative assessment of solitary thyroid nodules, diffuse and multi-nodular goiters with specificity ranging between 67%-100% and sensitivity ranging between 77.7%-93% (4) (5) (6) (7) (8) . T-FNAC diagnostic value is enhanced when combined with radiological investigations and thyroid function assays (6) . Its simplicity, cost effectiveness, good patient compliance and the minimum risk of complications enhances its value. T-FNAC is a forerunner in investigating thyroid nodules/ enlargements in our setting as well, resulting in a heavy thyroid cytology burden. It has possibly reduced the number of patients subjected to thyroidectomies and expensive isotope scans impacting our national healthcare cost.
Sri Lankan pathologists have performed and reported T-FNAC for the past two decades (9) . The reporting format for thyroid cytology in Sri Lanka (TCRSL) was compiled in 2007, based on the original 'Thy' classification of the British Thyroid Association and the Royal College of Pathologists of the United Kingdom (10, 11) . Without doubt TCRSL has made thyroid cytology reporting more uniform in our setting. However, TCRSL does not include clinical management guidelines, which is now felt as one of its major deficiencies (12) .
The Bethesda thyroid study group introduced 'The Bethesda System for Reporting Thyroid Cytology (BSRTC) in the same year (13) . BSRTC has standardized reporting and the management by linking diagnostic categories with clinical management guidelines (13) . As it is felt to offer a clearer platform of communication among cytopathologists and clinicians, BSRTC is adopted by many countries worldwide. BSRTC is also credited with increasing the interobserver agreement (IOA) among diagnostic categories, improving the predictive value of diagnoses (14) . However, it has more diagnostic categories than TCRSL (6 vs. 5) with a possible impact on the IOA.
Adopting a uniform thyroid cytology reporting format will allow easy comparison of data across borders, achieving the best use of cytology reporting. The Sri Lankan cytopathologists and the clinicians are yet relatively unfamiliar with BSRTC and the diagnostic outcome, compared to TCRSL. Therefore, IOA of BSRTC and TCRSL was compared with the view of providing scientific evidence to evaluate the appropriateness of adopting BSRTC in Sri Lanka.
Materials and Methods
Ethical approval was obtained from the ethics committee of the Faculty of Medicine, University of Colombo. The study sample was selected retrospectively from T-FNAC performed and reported by the department from January 2008-May 2012. The inclusion criteria included availability of all original smears in good condition and clinical information (age, sex, type of thyroid enlargement, sites of aspiration with clinical/radiological findings, thyroid function status). Stratified random sampling was used to select 100 T-FNAC fulfilling the inclusion criteria. This sampling method was used in order to include all diagnostic categories in the sample, minimizing the effect of prevalence. The serial number and clinical information obtained from clinical records were entered into a data record form as clinical variables. Individual diagnostic categorization was based on TCRSL followed by BSRTC. The evaluation was performed on separate occasions by two pathologists, each functioning independently.
The two pathologists were provided with the case histories and clinical findings, whilst being blinded to the previous diagnosis. The data record form was filled with the diagnosis based on one reporting format at any given time (TCRSL or BSRTC) by a pathologist (observer) after evaluating all the available smears of each case. Data was tabulated in SPSS version 20. The proportions of agreement and the composite agreements were calculated in all categories of both reporting formats. The IOA was analysed by calculating the Cohen kappa co-efficient for both TCRSL and BSRTC. Both unweighted kappa values and linear weighted kappa values were calculated as a measure of discrepancy between the diagnoses in TCRSL and BSRTC. Values of the Cohen kappa were interpreted as follows: 0 to 0.2, slight agreement; 0.21 to 0.40, fair agreement; 0.41 to 0.60, moderate agreement; 0.61 to 0.80, substantial agreement and 0.81 to 1; as almost perfect agreement (15) .
Results
The 100 T-FNAC included 9 males and 91 females between 15-76 years of age. Majority had multinodular goiters (43%) while 29% had solitary thyroid nodules. 23% had diffuse gland enlargement, 3% a single lobe enlargement and 2% with minimal/no macroscopically visible thyroid enlargement.
The diagnostic categories of TCRSL and BSRTC and the frequency distribution are depicted in Tables 1, 2 and 3 . Both observers were in complete agreement in diagnosing inadequate smears in 7 out of 16 (43%) in TCRSL and 6 out of 12 (50%) non-diagnostic or unsatisfactory smears in BSRTC. Observer 1 had given 16 inadequate/non diagnostic diagnosis in TCRSL and 12 in BSRTC, a higher frequency compared to observer 2. For the diagnosis of benign category/lesion the frequency of agreement was 52/78 (66%) by both observers in TCRSL, while it was 54/76 (71%) in BSRTC (Tables 4 and 5 ). The (Atypia of undetermined significance/Follicular lesion of undetermined significance) AUS/FLUS category of BSRTC showed the highest variability in the frequency of agreement as the two observers agreed only on 2/19 cases (10%), in AUS/FLUS diagnoses. The frequency of agreement for suspicious for follicular neoplasm/follicular neoplasm category in TCRSL was 4/24 (16%), where as it was 2/10 (20%) for BSRTC. The categories suspicious for malignancy and malignant had frequencies of agreement of 0 and 5 (71%) in TCRSL and 2 (33%) and 4 (57%) in BSRTC respectively. Table 1 ). This modified 'Thy' classification addresses the need for uniformity. The 'Thy3' category is now refined as 'Thy3a' and 'Thy 3f'. We in Sri Lanka however have not incorporated these modifications to our national guidelines. Even the current unmodified Thy classification based on TCRSL did not show a significant difference among the kappa values compared to BSRTC. However, it should be kept in mind that using kappa has its own limitations.
T-FNAC, in addition to having a high negative predictive value is documented to have a sensitivity and specificity ranging from 77.7%-93% and 67%-100% respectively (4) (5) (6) (7) (8) .
In order to maintain a high level of sensitivity and specificity while optimizing clinical care, it is necessary to have a robust and reproducible terminology for reporting thyroid cytology. BSRTC is widely adopted in the U.S.A and in many other developed countries due to its high sensitivity, high negative predictive value and also for its superiority in guiding the clinical management of patients (19) . Thus, BSRTC with all its merits is an option. This is especially in view of its linkage with clinical management guidelines; interobserver agreement and the easy transition from TCRSL to BSRTC as shown in the present study. The utility of evidence based medicine tools are not commonly seen in pathology while it is the governing trend in clinical medicine. While systematic reviews, meta-analysis and randomised control trials are accepted as the best available high quality evidence in clinical medicine, most attempts to develop pathology guidelines and recommendations have been based on observational studies or subjective views (21) . The availability of primary studies representing different settings is valuable in getting high quality evidence in the field of pathology as well. We hope the findings of this study would initiate and promote further study supporting evidence based development of guidelines and recommendations for thyroid cytology reporting in Sri Lanka.
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